| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/19/2007 | CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2107476C Pharmaceutical packaging unit containing plasminogen activators for multiple bolus administration |
| 12/13/2007 | WO2007142308A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142231A1 Agent for improvement in blood fluidity |
| 12/13/2007 | WO2007141495A1 Therapeutic uses of tomato extracts |
| 12/13/2007 | WO2007140982A1 Substituted benzoxazoles |
| 12/13/2007 | WO2007140681A1 The use of cucurbitacins or cucurbitacin compositions in preparation of medicaments for raising leukocytes |
| 12/13/2007 | WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor |
| 12/13/2007 | US20070287723 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286858 Methods and Compositions for Antagonism of RAGE |
| 12/13/2007 | US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1) |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections |
| 12/13/2007 | DE102006027163A1 Substituierte Benzoxazole Substituted benzoxazole |
| 12/13/2007 | CA2652908A1 Therapeutic uses of tomato extracts |
| 12/12/2007 | EP1865058A1 Anti-cd-20 monoclonal antibody |
| 12/12/2007 | EP1864984A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 12/12/2007 | EP1864982A1 Triamine derivative |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864979A1 Imidazole-derivatives as TAFAIa-inhibitors |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1864662A1 Therapeutic agent for thrombosis |
| 12/12/2007 | EP1863778A2 Spirocyclic thrombin receptor antagonists |
| 12/12/2007 | EP1863519A1 Monitoring and modulating hgf/hgfr activity |
| 12/12/2007 | EP1863463A1 Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/12/2007 | CN101085802A Method for preparing Notoginsen triterpenes |
| 12/12/2007 | CN101085297A Traditional Chinese medicine freeze dried injection for curing cerebral infarction and preparation method thereof |
| 12/12/2007 | CN101085295A Freeze dried injection containing muskone and preparation method thereof |
| 12/12/2007 | CN101085290A Oral administration traditional Chinese medicine composition for treating diabetes insipidus |
| 12/12/2007 | CN101085229A Medicine for treating cerebral thrombus |
| 12/12/2007 | CN101085226A 'Mailuoning' powder injection and its preparation method |
| 12/12/2007 | CN101085224A 'Mailuoning' injection preparation and its quality control method |
| 12/12/2007 | CN101084967A Extracting and purifying technology for safflower flavonoids |
| 12/12/2007 | CN101084963A Porridge containing notoginseng with hemostatic function |
| 12/12/2007 | CN101084962A Adsorption clarification method in preparing notoginseng total saponins |
| 12/12/2007 | CN101084953A Method for preparing acanthopanax senticousus extracting liquid/extraction |
| 12/12/2007 | CN101084923A Method for preparing rabbit against human T lymphocytes immune serum |
| 12/12/2007 | CN101084911A Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 12/12/2007 | CN101084889A Ginkgolide freezing-dried powder injection and preparation method thereof |
| 12/12/2007 | CN101084878A Blood dialysate dry powder containing citrate |
| 12/12/2007 | CN100353999C Pharmaceutical compositions of fibrinolytic agent |
| 12/12/2007 | CN100353997C Stabilized preparation containing protein |
| 12/12/2007 | CN100353967C Preparation of blood-nourishing Angelica capsule |
| 12/12/2007 | CN100353950C Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 12/12/2007 | CN100353936C Ferulaic acid sodium transfusion and prescription and preparation thereof |
| 12/11/2007 | US7307150 Dextran-hemoglobin conjugates as blood substitutes |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
| 12/11/2007 | US7306950 Composition and use of substances for stabilising amino acids containing sulphur |
| 12/11/2007 | CA2294448C Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 12/11/2007 | CA2221865C Bradykinin analogs as selective thrombin inhibitors |
| 12/11/2007 | CA2188463C Pharmaceutical compositions containing activated protein c-resistant factor v for the treatment of bleeding disorders |
| 12/06/2007 | WO2007139939A2 Methods and compositions using immunomodulatory compounds in combination therapy |
| 12/06/2007 | WO2007139208A1 Pharmaceutical composition for prevention or treatment of disease associated with platelet adhesion/aggregation reaction, and method for screening for the same |
| 12/06/2007 | WO2007138239A1 Cucurbitacine analogs or an extract from trichosanthes for treating anemia |
| 12/06/2007 | WO2007137801A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof |
| 12/06/2007 | WO2007137800A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof |
| 12/06/2007 | WO2007137793A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 12/06/2007 | WO2007137792A1 Substituted heterocycles and use thereof |
| 12/06/2007 | WO2007137791A1 Aryl-substituted heterocycles, and use thereof |
| 12/06/2007 | WO2007137790A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof |
| 12/06/2007 | WO2007115315A3 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282095 Thrombin Derivatives And Medicinal Composition Containing The Same |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070281964 Novel Crystalline Polymorphs of Clopidogrel |
| 12/06/2007 | US20070281941 Dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- alpha ]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; diabetes, obesity, and high blood pressure |
| 12/06/2007 | US20070281889 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070280920 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | DE102006025319A1 Substituierte Heterozyklen und ihre Verwendung Substituted heterocycles and their use |
| 12/06/2007 | DE102006025318A1 Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung Dihydro-pyrrolopyridin-, dihydro-pyrrolopyridazin- and dihydro-pyrrolopyrimidine derivatives and their use |
| 12/06/2007 | DE102006025317A1 Isoindolin-1-on-,Isoindolin-3-on und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use |
| 12/06/2007 | DE102006025316A1 Isoindolin-1-on-, Isoindolin-3-on- und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use |
| 12/06/2007 | DE102006025315A1 Tetrahydro-pyrrolopyridin-, Tetrahydro-pyrazolopyridin-, Tetrahydro-imidazopyridin- und Tetrahydro-triazolopyridin-Derivate und ihre Verwendung Tetrahydro-pyrrolopyridin-, tetrahydro-pyrazolopyridin-, tetrahydro-imidazopyridine and tetrahydro-triazolopyridine derivatives and their use |
| 12/06/2007 | DE102006025314A1 Arylsubstituierte Heterozyklen und ihre Verwendung Aryl-substituted heterocycles and their use |
| 12/06/2007 | CA2820391A1 Recombinant or transgenic factor vii composition, each factor vii molecule having two n-glycosylation sites with defined glycan units |
| 12/06/2007 | CA2653675A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydroimidazopyridine and tetrahydrotriazolopyridine derivatives and their use |
| 12/06/2007 | CA2653673A1 Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione derivatives and their use |
| 12/06/2007 | CA2653672A1 Dihydro-pyrrolopyridine, dihydro-pyrrolopyridazine and dihydro-pyrrolopyrimidine derivatives and their use |
| 12/06/2007 | CA2653670A1 Substituted heterocycles and their use |
| 12/06/2007 | CA2653665A1 Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione-derivatives and their use |
| 12/06/2007 | CA2652888A1 Methods and compositions using immunomodulatory compounds in combination therapy |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1861356A1 Imines as ion channel modulators |
| 12/05/2007 | EP1861124A2 Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch |